The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I've only posted here on AVCT a few times before but I said at those times that the Affimer technology would never work. Its not sensitive in the first place, and it isn't an amplification technology like PCR. There's probably a lot of grey areas that the company has chosen not to let us know about. But they raised £40M off the back of it and continue to burn cash like firewood. I've never bought AVCT, so no skin in the game anyway
The Centre for Countering Digital Hate is doing a pretty terrific job of pointing out the futility of engaging with trolls. Its report points out that trolls deliberately seek out engagement as a way of boosting their own profiles. And it works. Happy Christmas and make your New Year resolution to block the trolls that infest the LSE boards. The make their money by robbing you of yours.
Why are you posting Lloyd88? Altruistic chap trying to save everyone a few quid? If you don’t like the company, why not spend your time on something that matters financially to you? Because you’re a day trader, not an investor. Simple.
Your posts are repetitive, stupid, and wrong. And repetitive. And wrong.
A short scroll through their pronouncements this morning will reveal them all to be full of s**t with little predictive powers, or insight of any sort. Give yourself an early Christmas present and add them to your blocked list. Waste of space., distraction, derampers, and not in any way invested in a positive outcome for our holdings.
Lloyd88
PennyStockGrowth
MIDOXD
Jaceorge
Philipjo
Bonkers2021
GeordieShores
GloriaMarket
A short scroll through their pronouncements this morning will reveal them all to be full of s**t with little predictive powers, or insight of any sort. Give yourself an early Christmas present and add them to your blocked list. Waste of space., distraction, derampers, and not in any way invested in a positive outcome for our holdings.
Lloyd88
PennyStockGrowth
MIDOXD
Jaceorge
Philipjo
Bonkers2021
GeordieShores
GloriaMarket
GeordieShore you are unfortunately typical of almost everyone that posts now on this useless board. They don’t make LFTS, there are no Chinese competitors, and anyone that things they’re drumming up millions of sales a week after CE marketing is clearly a deramping fu**ing idiot.
No you can’t. Lying derampers (like Philjpo!). That’s why you should ignore anyone obviously deramping an AIM stock - they’re just trying to get in on the cheap. If you truly were a holder, what the point if trashing a stock you own? If you’re a holder and you don’t believe in it’s prospects, you’d sell, wouldn’t you? Unless your Philjpo. You think you have some sort of company insight ( even though evidence suggest you clearly don’t), can weather the storm for 5 years and you’re onto the next Amazon.
A Board isn’t involved with sales. Boards are about strategy and corporate governance. Secondly, they only just CE marked and the research they do to get that gives the product it’s performance specifications.. No customer or distributor is even going to look at a product before they know the specifications, and even then they’ll want product to evaluate because no one believes the performance number that companies attach to these covid products, LFTs said the were 98% this and 100% that, but we all know they’re actually quite poor. The idea that sales begin the day after CE marking is fantasy.
Covid to hit the NHS for the next 5 years and testing needed for the next 10.
https://ground.news/article/nhs-will-be-plagued-by-covid-for-at-least-five-years
Omega Diagnostics (UK, Mkt Cap £131.5m) Has launched its VISITECT COVID-19 Antigen test, a rapid point-of-care lateral flow diagnostic test for the detection of active COVID-19 infection. The test has sensitivity of 98.4% on samples with a cycle threshold (Ct) of < 20 (85% overall sensitivity on samples with Ct values ranging from 9.8 to 43) and specificity of 97.8%. The company also states that it is waiting for confirmation if test has successfully passed the Department of Health and Social Cares performance evaluations. Down -2.0% today.
Dr Cox says... "In a post vaccine world 1 cannot see how lateral flow tests with such low accuracy will stand the test of time. PCR (like the Genedrive announcement today, below) and vaccination is how COVID will be managed going forward. Lateral flow for COVID-19 infection has little use after things open up in line with vaccination in my opinion."
• Genedrive (UK, Mkt Cap £57.0m) — Announces that its COVID 19 PCR test (96 SARS-CoV-2 Kit) has been formally approved by the Indian Council of Medical Research (ICMR). The kit achieved 100% sensitivity and 100% specificity in the performance evaluation conducted by ICMR. The Company will now commence commercial activities in India through its existing distributor Divoc Health and will also be seeking additional routes to the market. Up +24.1% today.
This is the type of day that all LTNs should close the laptop, sit in the garden, and let the bottom feeders and Twittersphere twist eat themselves alive. Why stress yourself out? None of them have a clue what they are talking about.
He’s already told you the news. Problem is it’s not good news. Companies aren’t there to roll out news to meet the daily chat requirements of the lse board. He can’t predict the future - he can only give you news as it happens, if there’s no news, there’s nothing to say.
“Small shareholder group”. Him and his Mum I presume.
05:40 oilisgold: Same CEO that let the share price reach 300p knowing well he was doing a placing. I am suprised no legal action has been taken against GDR. I will be forming a small share holder group to take legal action.